# APIXABAN
> **ANDA209898** · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2020-09-11
## Drug
- **FDA Application Number:** ANDA209898
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APIXABAN
- **Generic name:** APIXABAN
- **Active ingredients:** APIXABAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** REGCON HOLDINGS
- **Manufacturer:** Indoco Remedies Limited
- **First approval:** 2020-09-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209898)
---
*AI Analytics · CC0 1.0*